A Non Invasive Biomarkers for Alzheimer’s disease Detection

Alzheimer's disease (AD) is one of the most common neurodegenerative diseases occurring in elderly population worldwide, which usually starts slowly and worsens over time. AD is generally diagnosed too late, when irreversible damages have been caused in the patient’s brain region. Present need demands the discovery of diagnostic and prognostic patient specific effective biomarkers to improve patient’s life quality and avoid big healthcare costs. Objective of this survey is to review the non-invasive biomarkers that could be used to predict early onset of AD and delay cognitive impairment.